[The treatment of chronic lymphatic leukemia].
D045930:Anabolic Agents / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007239:Infections / Q000209:etiology; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D005719:gamma-Globulins / Q000627:therapeutic use
D045930:Anabolic Agents; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D005719:gamma-Globulins; D002699:Chlorambucil; D003520:Cyclophosphamide
Die Behandlung der chronischen lymphatischen Leukämie.